The INHALE-3 extension study found that a regimen of inhaled technosphere insulin and insulin degludec reduced post-meal hyperglycemia in adults with type 1 diabetes. The treatment showed significant improvements in mean time in range, with 43% of participants expressing interest in continuing the regimen.
SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalDiabetes Technology & Therapeutics·TypeRandomized controlled/clinical trial·DateMar 22, 2025
A new study from the University of Surrey found that healthcare professionals face difficulties in recognizing and addressing disordered eating in people with type 1 Diabetes due to lack of support and limited confidence. This can lead to delays in diagnosis and potentially life-threatening complications for patients.
SourceUniversity of Surrey·JournalDiabetic Medicine·DateMar 20, 2025
Apple iPad Pro 11-inch (M4)
Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.
A phase 1/2 clinical trial is exploring whether denosumab, an osteoporosis medication, can protect and regenerate beta cells in people with early type 1 diabetes. The study aims to improve blood sugar control by preserving beta cell function.
Researchers emphasize the importance of regular screenings and treatment to prevent vision loss in patients with diabetes. Current guidelines recommend eye exams for adults with type 1 and type 2 diabetes, while adolescents and young adults are at higher risk due to difficulty controlling their condition.
SourceMichigan Medicine - University of Michigan·JournalDiabetes Technology & Therapeutics·TypeLiterature review·DateMar 12, 2025
A new study from Washington State University finds automated insulin delivery systems safe and effective for older adults with type 1 diabetes, improving glucose control and reducing burden. The hybrid closed loop system proved most effective at keeping blood sugar in target range.
SourceWashington State University·JournalNEJM Evidence·DateMar 11, 2025
Research in mice found that early-life gut microbes shape insulin-producing cell development and reduce long-term changes in metabolism and diabetes risk. Exposure to a fungus called Candida dubliniensis during infancy may also promote lifelong metabolic health by supporting the growth of insulin-producing cells.
SourceUniversity of Utah Health·JournalScience·TypeExperimental study·DateMar 6, 2025
Researchers analyzed phage-bacteria communities in children's stool samples to understand their role in type 1 diabetes development. They found dynamic changes in phage and bacterial populations, suggesting an 'arms race' between the two, but no clear link to disease risk.
SourceBaylor College of Medicine·JournalNature Microbiology·TypeComputational simulation/modeling·DateFeb 25, 2025
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
Researchers at the University of Colorado Anschutz Medical Campus found that primary care providers trained on advanced insulin technology or through telehealth can deliver similar positive results to specialists. The study focuses on Type 1 diabetes and highlights the potential for broader access to cutting-edge care.
SourceUniversity of Colorado Anschutz Medical Campus·JournalClinical Diabetes·DateFeb 24, 2025
Researchers identified GPR107 as a key regulator of COL4 levels in the kidney, finding that reduced GPR107 contributes to harmful COL4 accumulation and kidney damage. Strategies aimed at restoring or enhancing GPR107 function could represent a novel approach to preventing diabetic nephropathy progression.
SourceSichuan International Medical Exchange and Promotion Association·JournalMolecular Biomedicine·DateFeb 23, 2025
Researchers developed reprogrammed vascular endothelial cells that provide strong support for islets, allowing them to survive and reverse diabetes long-term. The study showed that mice transplanted with islet cells plus R-VECs regained normal blood glucose control after 20 weeks.
SourceWeill Cornell Medicine·JournalScience Advances·DateFeb 21, 2025
A study comparing hybrid closed-loop and open-loop systems in young people with type 1 diabetes found that hybrid closed-loop systems offered improved long-term blood sugar values, a lower risk of hypoglycemic coma, but a higher rate of diabetic ketoacidosis. The results suggest that hybrid closed-loop therapies may be beneficial for i...
SourceDeutsches Zentrum fuer Diabetesforschung DZD·JournalThe Lancet Diabetes & Endocrinology·TypeObservational study·DateFeb 12, 2025
A new study published in JSCAI reveals a lower risk of cardiovascular events for people with Type 1 diabetes, compared to those with Type 2 diabetes. The research highlights the importance of distinguishing between the two types of diabetes and developing targeted treatment strategies.
SourceSociety for Cardiovascular Angiography and Interventions·JournalJournal of the Society for Cardiovascular Angiography & Interventions·DateFeb 12, 2025
CalDigit TS4 Thunderbolt 4 Dock
CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.
A new clinical trial at UVA is testing an innovative AI-powered device designed to improve automated insulin delivery, aiming to simplify diabetes management. The trial will evaluate the 'Bolus Priming System with Reinforcement Learning' technology in adult participants with Type 1 Diabetes.
SourceUniversity of Virginia School of Data Science·TypeRandomized controlled/clinical trial·DateFeb 11, 2025
A new study found that yo-yo dieting significantly increases the risk of kidney disease in people with type 1 diabetes. Participants who experienced greater weight fluctuations had a 40% decline in estimated glomerular filtration rate and were more likely to exhibit increased albuminuria.
SourceThe Endocrine Society·JournalThe Journal of Clinical Endocrinology & Metabolism·DateFeb 4, 2025
Researchers found that time in safe blood-sugar range can predict diabetes complications as accurately as hemoglobin A1c levels. The study used advanced machine learning techniques to analyze landmark diabetes data from the DCCT trial.
SourceUniversity of Virginia Health System·JournalDiabetes Technology & Therapeutics·DateJan 15, 2025
Meta Quest 3 512GB
Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.
A new study from Aarhus University Hospital shows that fecal microbiota transplantation can be a safe and effective treatment for patients with type 1 diabetes and gastroenteropathy. The treatment has significantly improved quality of life and symptoms for participants, offering hope to those with debilitating symptoms.
SourceAarhus University·JournalEClinicalMedicine·TypeRandomized controlled/clinical trial·DateJan 8, 2025
A Stanford Medicine study found that AI can help researchers quickly evaluate large amounts of medical data, identifying trends and patterns. The tool was trained on notes from 1,201 children with ADHD, allowing researchers to pinpoint gaps in follow-up care and identify tactics to improve ADHD management.
SourceStanford Medicine·JournalPEDIATRICS·TypeData/statistical analysis·DateDec 20, 2024
Researchers have found that loosening the grip of engineered chimeric antigen receptor (CAR) Tregs improves their function and effectiveness in treating autoimmune diseases. By adjusting the affinity of the CAR, the study shows that Tregs can suppress immune responses while reducing pro-inflammatory consequences.
SourceMedical University of South Carolina·JournalMolecular Therapy — Methods & Clinical Development·DateDec 19, 2024
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C)
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C) keeps Macs, tablets, and meters powered during extended observing runs and remote surveys.
Mount Sinai researchers have made significant progress in understanding how human beta cell regenerative drugs work, potentially leading to a cure for diabetes. The study suggests that these drugs may be able to induce lineage conversion in human pancreatic islets, providing a new source of beta cells.
SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalCell Reports·TypeExperimental study·DateDec 11, 2024
Scientists at UCSF have developed engineered T cells that act as immune referees to soothe overreacting immune responses and mope up inflammatory molecules. These cells could improve treatment for organ transplants, type 1 diabetes and other autoimmune conditions by reducing the need for harsh immunosuppressant drugs.
SourceUniversity of California - San Francisco·JournalScience·DateDec 5, 2024
A new study found that factors beyond carbohydrates, such as exercise and hormones, play a substantial role in regulating blood glucose levels in people with Type 1 Diabetes. The research highlights the complexity of glucose regulation and the need for personalized insulin dosing approaches.
SourceUniversity of Bristol·JournalJMIRx Med·TypeData/statistical analysis·DateNov 27, 2024
Lantidra is the only FDA-approved treatment for brittle type 1 diabetes, a more severe form of the disease. The therapy involves pancreatic islet cell transplantation and has shown promising results in clinical trials, with most patients no longer requiring insulin one year after the procedure.
Kestrel 3000 Pocket Weather Meter
Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.
Researchers at Medical University of South Carolina and University of Florida developed a novel approach to treat type 1 diabetes using tagged beta cell transplant with localized immune protection. The study, published in Cell Reports, shows promise for creating an off-the-shelf solution for T1D treatment.
SourceMedical University of South Carolina·JournalCell Reports·DateNov 25, 2024
A new research grant aims to develop kinase inhibitors for treating type 1 diabetes, with a focus on preventing and reversing the condition. The grant is made through C-Path's TRxA program in partnership with The Leona M. and Harry B. Helmsley Charitable Trust.
A new system combining high-speed video and an AI algorithm can detect high blood pressure and Type 1 or Type 2 diabetes from subtle changes in blood flow, potentially leading to early detection and treatment. The technology is still in its preliminary stages but holds promise for non-invasive monitoring of health at home.
The TEDDY study aims to understand the causes of type 1 diabetes in children, finding a connection between enterovirus infection, autoantibodies, and disease development. Probiotics may also reduce risk in infants at high danger of developing diabetes-related antibodies.
SourceLund University·JournalNature Reviews Endocrinology·DateNov 4, 2024
Researchers developed a screening technique to filter out low-quality data in wearable sensors, improving the performance of smartwatches for noninvasive blood glucose estimation. The approach enhances accuracy by discarding data with high phase errors and approximating missing values.
SourceSPIE--International Society for Optics and Photonics·JournalJournal of Biomedical Optics·DateOct 28, 2024
Aranet4 Home CO2 Monitor
Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.
The use of GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors in people with type 1 diabetes has significantly increased between 2010 and 2023. This trend is driven by their benefits in weight management and cardiorenal protection, but caution is advised due to concerns about euglycemic diabetic ketoacidosis.
Cognitive-behavioral therapy (CBT) is a promising intervention for addressing medical non-adherence in pediatric patients with chronic illnesses. CBT successfully integrates principles of learning theory and cognitive science to address behavioral and emotional challenges that affect health outcomes.
SourceXia & He Publishing Inc.·JournalJournal of Exploratory Research in Pharmacology·DateOct 21, 2024
A McGill University study reveals that vitamin D deficiency early in life can lead to a higher risk of autoimmune diseases like Type 1 diabetes. The research found that an aging thymus causes the immune system to become less effective, increasing the risk of misdirected immune cells attacking healthy tissues.
SourceMcGill University·JournalScience Advances·TypeExperimental study·DateOct 21, 2024
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
Researchers at University of Gothenburg propose inhibiting somatostatin to restore glucagon release and prevent dangerous blood sugar levels. This approach has the potential to save lives and is supported by experimental results in mice with type 1 diabetes.
SourceUniversity of Gothenburg·JournalNature Metabolism·DateSep 30, 2024
A large study found that women with premature ovarian insufficiency are 2.6 times more likely to have an autoimmune disorder, with some conditions increasing the risk by 26 times. The study suggests a strong link between POI and severe autoimmune diseases, highlighting the need for medical professionals to be aware of this increased risk.
SourceEuropean Society of Human Reproduction and Embryology·JournalHuman Reproduction·TypeObservational study·DateSep 25, 2024
A new large-scale longitudinal study will investigate the environmental, lifestyle, social, and clinical factors affecting brain development in children with type 1 diabetes. The five-year study aims to refine clinical guidelines and targeted treatments for children with diabetes.
A new study found that adults with type 1 diabetes are hesitant to exercise due to fear of hypoglycaemia, a concern exacerbated by limited understanding of insulin dose adjustments and carbohydrate intake for physical activity. Education on exercise safety and dialogue within clinics can help break down barriers.
A new hybrid closed-loop technology has been shown to enable people with type 1 diabetes to run marathons with excellent glucose control. The technology, called AID system, automates insulin delivery based on sensor glucose values, allowing for safer and healthier lives.
DJI Air 3 (RC-N2)
DJI Air 3 (RC-N2) captures 4K mapping passes and environmental surveys with dual cameras, long flight time, and omnidirectional obstacle sensing.
Researchers found that semaglutide and tirzepatide led to significant weight loss (9.1% and 21.4%, respectively) and improved blood sugar control in patients with type 1 diabetes. Weight loss was associated with reduced insulin dose, indicating improved insulin resistance.
A new class of weekly insulin, efsitora alfa, has been shown to be non-inferior to daily injections in managing blood sugar levels in patients with type 1 diabetes. However, the study found higher rates of hypoglycaemia, highlighting the need for vigilance in dose initiation and optimization.
Research links impaired circadian heart rate fluctuations to microvascular disease and increased long-term risk of cardiovascular mortality in people with diabetes. Disrupted daily heart rate variations are associated with a doubled risk of dying from cardiovascular causes.
Research suggests that eating fruit, oats, and rye in childhood increases the risk of developing type 1 diabetes, but consuming berries may lower this risk. The study followed thousands of children in Finland from birth to age six and found associations between specific foods and an increased or decreased risk of islet autoimmunity.
GoPro HERO13 Black
GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.
Researchers found that altitude changes during flights may cause slight increases and decreases in insulin delivery, potentially leading to blood glucose fluctuations. Individuals using insulin pumps should be aware of these effects and consider temporarily disconnecting their pumps before take-off.
Scientists discovered the highest natural blood sugar levels in mammals, found in a species of bats that can survive on a diet rich in sugars. The study's findings suggest that these bats have evolved unique strategies for glucose regulation, which may hold potential for managing metabolic diseases in humans.
SourceStowers Institute for Medical Research·JournalNature Ecology & Evolution·TypeExperimental study·DateAug 28, 2024
Researchers found that people with chronic diabetes complications are up to three times more likely to have a mental health condition, while those with mental health disorders are up to two and a half times more likely to experience sustained diabetes complications. The study highlights the importance of screening for both risk factors.
SourceMichigan Medicine - University of Michigan·JournalDiabetes Care·TypeData/statistical analysis·DateAug 22, 2024
Sky-Watcher EQ6-R Pro Equatorial Mount
Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.
Texas A&M researchers are investigating the use of extracellular vesicles to deliver immune-suppressing proteins, potentially reducing the immune system's attack on insulin-producing beta-cells. The goal is to develop a novel treatment for type 1 diabetes, which currently has only lifelong insulin therapy as an approved option.
Research suggests that exposure to type 1 diabetes in the womb confers long-term protection against the condition in children with affected mothers, but not fathers. The study found a relative risk of 1.8 for children diagnosed with T1D if their father has the condition compared to those with affected mothers.
A recent paper surveys advances in diabetes pathogenesis and treatment, highlighting the role of genes, environmental factors, and social determinants. The study suggests that understanding these dynamics is key to developing targeted interventions to reduce diabetes risk and manage its complications.
SourceUniversity of California - Los Angeles Health Sciences·JournalCell·TypeLiterature review·DateJul 25, 2024
The risk of developing type 1 diabetes (T1D) decreases in girls after age 10, while the risk in boys remains stable. Males with a single autoantibody have a significantly higher risk of T1D than their female counterparts.
SourceEuropean Association for the Study of Obesity·DateJul 22, 2024
Children diagnosed with type 1 diabetes are at significantly higher risk of mood and anxiety disorders, as well as behavioral syndromes. The study highlights the urgent need for monitoring and support for their mental health.
SourceUniversity of Cambridge·JournalNature Mental Health·TypeData/statistical analysis·DateJul 17, 2024
Rigol DP832 Triple-Output Bench Power Supply
Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.
A follow-up study found that COVID-19 infection accelerated the progression from pre-symptomatic to clinical type 1 diabetes in youth, with no observed effect in adults. Further research is needed to determine whether vaccination and monitoring for COVID-19 symptoms can help prevent or delay this progression.
Researchers identified two distinct T-cell signatures in children with newly diagnosed type 1 diabetes and those at risk of developing the disease. These signatures may serve as potential biomarkers and targets for preventive immunotherapy treatments.
SourceUniversity of Eastern Finland·JournalDiabetes·DateJul 11, 2024
Researchers from Mount Sinai and City of Hope demonstrate a combination treatment that increases human insulin-producing beta cells by 700% in mice with diabetes. This breakthrough could lead to new treatments for the hundreds of millions of people with diabetes worldwide.
SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalScience Translational Medicine·DateJul 10, 2024
A six-year study found that consuming diets more closely aligned with the Mediterranean and DASH diets can lower levels of harmful blood markers and reduce cardiovascular disease risk. These dietary patterns emphasize plant-based foods, healthy fats, lean proteins, and low intake of processed foods and sugars.
The number of people aged 65 and older with type 1 diabetes increased from 1.3 million to 3.7 million between 1990 and 2019, while death rates fell by 25%. However, substantial global inequalities in diabetes care persist, with higher mortality rates in low- and middle-income countries.
SourceBMJ Group·JournalThe BMJ·TypeObservational study·DateJun 12, 2024
Davis Instruments Vantage Pro2 Weather Station
Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.
A new study led by researchers at UC San Francisco found that a virtual emotion-centered program called TunedIn can reduce diabetes distress by half and improve glucose control. The program incorporates elements of Acceptance and Commitment Therapy and was delivered virtually to 276 adults with Type 1 diabetes.
SourceUniversity of California - San Francisco·JournalDiabetes Care·DateJun 10, 2024
Aging human pancreatic beta cells display features of senescence but maintain elevated levels of genes crucial for function and exhibit an ability to release insulin in response to glucose. This sheds light on the potential role of aging beta cells in immune regulation and their relevance to autoimmune reactions in type 1 diabetes.
SourceThe Hebrew University of Jerusalem·JournalNucleic Acids Research·TypeExperimental study·DateJun 3, 2024
A new study aims to investigate whether vaccination against SARS-CoV-2 can protect children at increased genetic risk of developing type 1 diabetes. The AVAnT1A Study, the largest intervention study to date, examines the relationship between viral infections and early childhood development.
SourceHelmholtz Munich (Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH))·DateMay 8, 2024
A new NIH grant will investigate biological processes that contribute to defects in immune response in the eyes of those with diabetes. Researchers aim to understand why diabetic patients are more susceptible to corneal infections and identify methods to reverse these effects.
SourceWayne State University - Office of the Vice President for Research·DateMay 7, 2024
Researchers have discovered a repurposed cancer drug that can convert acinar cells into insulin-producing cells, which could provide a new avenue for treating diabetes. The treatment partially improved hyperglycemia and persisted without additional treatment in diabetic mice and non-human primates.
SourceUniversity of Pittsburgh·JournalNature Communications·TypeExperimental study·DateMay 6, 2024
Apple MacBook Pro 14-inch (M4 Pro)
Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.
An experimental monoclonal antibody drug called mAb43 appears to prevent and reverse the onset of clinical type 1 diabetes in mice, lengthening their lifespan. The drug targets insulin-making beta cells directly and shields them from immune system attacks, raising the possibility of a new treatment for the autoimmune condition.
SourceJohns Hopkins Medicine·JournalDiabetes·DateApr 29, 2024
Adults with type 1 diabetes who use modern hybrid insulin pumps experience significant improvements in blood sugar levels, reducing the risk of organ damage by up to three hours per day. The treatment also reduces the time spent with low blood sugar levels and is associated with high patient satisfaction.
SourceUniversity of Gothenburg·JournalJournal of Diabetes Science and Technology·TypeObservational study·DateApr 23, 2024
Researchers found a unique genetic mutation in the PD-L1 gene, essential for preventing autoimmune diabetes. The discovery sheds light on the role of PD-L1 in regulating immune cells and could lead to new treatments for the devastating disease.
SourceUniversity of Exeter·JournalJournal of Experimental Medicine·TypeCase study·DateApr 18, 2024
Celestron NexStar 8SE Computerized Telescope
Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.